Patents by Inventor Norbert Schaschke

Norbert Schaschke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cathepsin-binding compounds bound to a carrier and their diagnostic use
    Patent number: 10668175
    Abstract: The invention relates to Cathepsin-binding compounds bound to a carrier comprising a diagnostic moiety, for use in the diagnosis of inflammatory diseases, and/or for use in the diagnosis of neoplastic diseases, wherein the Cathepsin-binding compound binds to inflammatory cells of the tumour stroma. The invention also relates to Cathepsin B-targeting compounds and Cathepsin B-binding and liposome-binding compounds.
    Type: Grant
    Filed: October 24, 2017
    Date of Patent: June 2, 2020
    Assignee: J. Stefan Institute
    Inventors: Olga Vasiljeva, Georgy Mikhaylov, Boris Turk, Norbert Schaschke
  • CATHEPSIN-BINDING COMPOUNDS BOUND TO A CARRIER AND THEIR DIAGNOSTIC USE
    Publication number: 20180085479
    Abstract: The invention relates to Cathepsin-binding compounds bound to a carrier comprising a diagnostic moiety, for use in the diagnosis of inflammatory diseases, and/or for use in the diagnosis of neoplastic diseases, wherein the Cathepsin-binding compound binds to inflammatory cells of the tumour stroma. The invention also relates to Cathepsin B-targeting compounds and Cathepsin B-binding and liposome-binding compounds.
    Type: Application
    Filed: October 24, 2017
    Publication date: March 29, 2018
    Inventors: Olga VASILJEVA, Georgy MIKHAYLOV, Boris TURK, Norbert SCHASCHKE
  • Cathepsin-binding compounds bound to a carrier and their diagnostic use
    Patent number: 9827337
    Abstract: The invention relates to Cathepsin-binding compounds bound to a carrier comprising a diagnostic moiety, for use in the diagnosis of inflammatory diseases, and/or for use in the diagnosis of neoplastic diseases, wherein the Cathepsin-binding compound binds to inflammatory cells of the tumour stroma. The invention also relates to Cathepsin B-targeting compounds and Cathepsin B-binding and liposome-binding compounds.
    Type: Grant
    Filed: June 22, 2012
    Date of Patent: November 28, 2017
    Assignee: J. Stefan Institute
    Inventors: Olga Vasiljeva, Georgy Mikhaylov, Boris Turk, Norbert Schaschke
  • CATHEPSIN-BINDING COMPOUNDS BOUND TO A CARRIER AND THEIR DIAGNOSTIC USE
    Publication number: 20140227175
    Abstract: The invention relates to Cathepsin-binding compounds bound to a carrier comprising a diagnostic moiety, for use in the diagnosis of inflammatory diseases, and/or for use in the diagnosis of neoplastic diseases, wherein the Cathepsin-binding compound binds to inflammatory cells of the tumour stroma. The invention also relates to Cathepsin B-targeting compounds and Cathepsin B-binding and liposome-binding compounds.
    Type: Application
    Filed: June 22, 2012
    Publication date: August 14, 2014
    Applicant: J. Stefan Institute
    Inventors: Olga Vasiljeva, Georgy Mikhaylov, Boris Turk, Norbert Schaschke
  • Tryptase inhibitors
    Patent number: 6613769
    Abstract: The invention relates to bifunctional tryptase inhibitors of formula (I) wherein H1 and H2 comprise a Q group and L is a linker of formula and the conformation of the H1, H2 and L groups is such that the groups are separated by a distance of from 20 to 45 Å. Pharmaceutical compositions and crystal forms of the compounds are described in addition to methods for producing and identifying such compounds, as well as the use of such compounds in methods of treating allergic and inflammatory diseases.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: September 2, 2003
    Assignees: Max-Planck-Gesellschaft zur Föderung der Wissenschaften. e.V., Altana Pharma AG
    Inventors: Wolfram Bode, Luis Moroder, Pedro Jose Barbosa Pereira, Andreas Bergner, Robert Huber, Christian Sommerhoff, Norbert Schaschke, Thomas Bär, Thomas Martin, Josef Stadlwieser, Wolf-Rüdiger Ulrich, Andreas Dominik, Ulrich Thibaut, Daniela Bundschuh, Rolf Beume, Karl-Josef Goebel
  • Tryptase inhibitors
    Patent number: 6489327
    Abstract: The invention relates to novel inhibitors of human tryptase which are used in the pharmaceutical industry for the production of medicaments.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: December 3, 2002
    Assignees: Max-Planck-Gesellschaft zur Fordrungder Wisenschaften, e.V., Byk Gulden Lomberg Chemische Fabrik GmbH
    Inventors: Thomas Bär, Thomas Martin, Josef Stadlwieser, Wolf-Rüdiger Ulrich, Andreas Dominik, Ulrich Thibaut, Daniela Bundschuh, Rolf Beume, Karl-Josef Goebel, Wolfram Bode, Luis Moroder, Pedro Jose Barbosa Pereira, Andreas Bergner, Robert Huber, Christian Sommerhoff, Norbert Schaschke